Relationship between antimicrobial resistance and aminoglycoside-modifying enzyme gene expressions in Acinetobacter baumannii

Chinese Medical Journal

Volumn 118, Issue 2, 2005, Pages 141-145

  Shi, Wei Feng ^a   Jiang, Jian Ping ^a   Mi, Zu Huang ^b  

^a SOOCHOW UNIVERSITY   (China)

^b Wuxi Clone Gen Tech Institute   (China)

Author keywords

Acinetobacter baumannii; Aminoglycoside modifying enzyme; DNA sequence; Drug resistance

Indexed keywords

ACYLTRANSFERASE; AGAR; AMIKACIN; AMINOGLYCOSIDE; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; BETA LACTAM ANTIBIOTIC; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; KANAMYCIN; LEVOFLOXACIN; MEROPENEM; NEOMYCIN; NETILMICIN; PHOSPHOTRANSFERASE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; STREPTOMYCIN; SULTAMICILLIN; TETRACYCLINE; TOBRAMYCIN;

ACINETOBACTER BAUMANNII; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; CONTROLLED STUDY; DNA SEQUENCE; GENE AMPLIFICATION; GENE EXPRESSION; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION;

ACINETOBACTER BAUMANNII; AMINOGLYCOSIDES; BASE SEQUENCE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; GENOTYPE; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA;

EID: 13644268179     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Karlowsky JA, Draghi DC, Jones ME, et al. Surveillance for antimicrobial susceptibility among clinical isolates of pseudomonas aeruginosa and acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001. Antimicrob Agents Chemother 2003;47:1681-1688.
2. Landman D, Quale JM, Mayorga D, et al. Citywide clonal outbreak of multiresistant acinetobacter baumannii and pseudomonas aeruginosa in Brooklyn, NY: the preantibiotic era has returned. Arch Intern Med 2002;162:1515-1520.
3. Bou G, Oliver A, Martinez-Beltran J. OXA-24, a novel class D beta-lactamase with carbapenemase activity in an acinetobacter baumannii clinical strain. Antimicrob Agents Chemother 2000;44:1556-1561.
4. Davies J, Wright GD. Bacterial resistance to aminoglycoside antibiotics. Trends Microbiol 1997;5: 234-240.
5. Sophie M, Smith TA, Zheng RJ, et al. Aminoglycoside resistance resulting from tight drug binding to an altered aminoglycoside acetyltransferase. Antimicrob Agents Chemother 2003;47:1577-1583.
6. Vakulenko SB, Mobashery S. Versatility of aminoglycosides and prospects for their future. Clin Microbiol Rev 2003;16:430-450.
7. Llano-Sotelo B, Azucena EF Jr, Kotra LP, et al. Aminoglycosides modified by resistance enzymes display diminished binding to the bacterial ribosomal aminoacyl-tRNA site. Chem Biol 2002;9:455-463.
8. Fluit AC, Schmitz FJ. Class 1 integrons, gene cassettes, mobility, and epidemiology. Eur J Clin Microbiol Infect Dis 1999;18:761-770.
9. Wright GD. Aminoglycoside-modifying enzymes. Curr Opin Microbiol 1999;2:499-503.
10. Vila J, Ruiz J, Navia M. Spread of amikacin resistance in acinetobacter baumannii strains isolated in Spain due to an epidemic strain. J Clin Microbiol 1999;37:758-761.